Next Quarterly Earnings
Thursday, November 5, 2026
CW 45
After-Hours
In 70 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Rocket Pharmaceuticals
Rocket Pharmaceuticals is a leading US-based biotechnology company dedicated to developing transformative gene therapies. The company focuses on potentially curative treatments for patients with devastating, rare genetic diseases. As a clinical-stage company, Rocket Pharmaceuticals is driving innovative approaches to improve the lives of critically ill individuals worldwide and provide long-term solutions.
Frequently asked questions
When will Rocket Pharmaceuticals report its next quarterly earnings?
Rocket Pharmaceuticals is scheduled to report its next quarterly earnings on 11/05/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did Rocket Pharmaceuticals last report quarterly earnings?
Rocket Pharmaceuticals last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at 1.08 USD.
How does Rocket Pharmaceuticals stock react to earnings?
Across its last 3 earnings reports, Rocket Pharmaceuticals stock moved by ±4.5% on average the following day. The largest reaction was +10.6% on 02/26/2026; 1 of 3 reactions were positive.
How often has Rocket Pharmaceuticals beaten expectations?
Rocket Pharmaceuticals has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
How do I add the Rocket Pharmaceuticals earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±4.5%
Avg. next-day move
+10.6%
Largest move (02/26/2026)
33.3%
Share of positive reactions
±3.9%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
3/5
Quarters above estimates
60%
Beat rate
+2.3%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Rocket Pharmaceuticals
Country
🇺🇸
More Financial Information